![Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/6d0fb724-9766-4959-8a3d-180a77cde531/gr1.gif)
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet
![Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/94597f5b-8f00-4c9a-9442-ec00415b36da/gr1.jpg)
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet
![Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial - The Lancet Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/03197da1-e15f-4d52-bfd5-a54f3ccf9cec/gr1.gif)
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial - The Lancet
![Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5a3c1320-5d4d-42ba-bed6-e1060fa2102b/gr1.gif)
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet
![Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e4b6e22c-a577-4f6d-bc17-40a1641f69bf/gr1.gif)
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet
![https://gurushots.com/photo/ 2019-01-15T05:05:35+00:00 weekly 0.6 https://photos.gurushots.com/unsafe/0x0/1397727929c6114a54a4195c134a783c/3_b90d28c8db0c9215578f75d6c3931b65.jpg Bird Animal Robin Bird By Evelynerudisch https ... https://gurushots.com/photo/ 2019-01-15T05:05:35+00:00 weekly 0.6 https://photos.gurushots.com/unsafe/0x0/1397727929c6114a54a4195c134a783c/3_b90d28c8db0c9215578f75d6c3931b65.jpg Bird Animal Robin Bird By Evelynerudisch https ...](https://photos.gurushots.com/unsafe/0x0/887d628434f7b4f78a0e749f8a97b0a8/3_bc26a7e8354a8cdead764f5f069f5477.jpg)